CASI Pharmaceuticals
CASI
#10174
Rank
NZ$30.7 M
Marketcap
NZ$1.49
Share price
-2.13%
Change (1 day)
-65.84%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.57. In 2024 the company made an earnings per share (EPS) of NZ-$4.23 a decrease over its 2023 EPS that were of NZ-$3.34.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.6510.04%
2024NZ-$4.2326.73%
2023NZ-$3.34-32.89%
2022NZ-$4.9711.9%
2021NZ-$4.44-38.44%
2020NZ-$7.22-8.96%
2019NZ-$7.9350%
2018NZ-$5.2877.78%
2017NZ-$2.975.88%
2016NZ-$2.81-22.73%
2015NZ-$3.63-76.09%
2014NZ-$15.19318.18%
2013NZ-$3.63-71.79%
2012NZ-$12.8865.96%
2011NZ-$7.76-50%
2010NZ-$15.52-18.97%
2009NZ-$19.15-63.64%
2008NZ-$52.673.57%
2007NZ-$50.85-60.56%
2006NZ-$128.9597.22%
2005NZ-$65.38-2.7%
2004NZ-$67.20-45.59%
2003NZ-$123.50-61.8%
2002NZ-$323.29-25.52%
2001NZ-$434.07-21.38%
2000NZ-$552.1313.86%
1999NZ-$484.93149.53%
1998NZ-$194.3398.15%
1997NZ-$98.0810.2%
1996NZ-$88.99